Radiation Therapy for Colorectal Liver Metastases

Yushen Qian, Kiran A. Kumar, Sara Dudley, Albert C. Koong, Daniel T. Chang

Research output: Contribution to journalReview article

Abstract

Purpose of Review: The purpose of the present study is to review the management of colorectal liver metastases (CLM) with radiation therapy (RT). Recent Findings: Conventional RT is a local-regional modality that may provide symptomatic palliation, local control, and potential for prolongation of survival. Studies of RT to the liver contributed to understanding of the volume effect of liver toxicity and the potential for dose escalation to limited volumes. Stereotactic body radiation therapy (SBRT) delivers highly conformal ablative doses, providing high rates of local control without associated increases in toxicity. Radioembolization can provide local control for chemorefractory patients, but its added value in the first-line setting with modern systemic therapy remains an area of active investigation. Summary: SBRT and radioembolization play key roles in the modern management of patients with CLM who are not eligible for surgery. Patients with limited burden of intrahepatic disease may be ideally suited for SBRT, while those with higher number (≥3) of CLM may be more appropriate for transarterial radioembolization.

Original languageEnglish (US)
Pages (from-to)240-249
Number of pages10
JournalCurrent Colorectal Cancer Reports
Volume13
Issue number3
DOIs
StatePublished - Jun 1 2017
Externally publishedYes

Fingerprint

Radiotherapy
Neoplasm Metastasis
Liver
Survival
Therapeutics

Keywords

  • Colorectal liver metastases
  • External beam radiation therapy
  • Radioembolization
  • Stereotactic body radiation therapy

ASJC Scopus subject areas

  • Hepatology
  • Oncology
  • Gastroenterology

Cite this

Radiation Therapy for Colorectal Liver Metastases. / Qian, Yushen; Kumar, Kiran A.; Dudley, Sara; Koong, Albert C.; Chang, Daniel T.

In: Current Colorectal Cancer Reports, Vol. 13, No. 3, 01.06.2017, p. 240-249.

Research output: Contribution to journalReview article

Qian, Yushen ; Kumar, Kiran A. ; Dudley, Sara ; Koong, Albert C. ; Chang, Daniel T. / Radiation Therapy for Colorectal Liver Metastases. In: Current Colorectal Cancer Reports. 2017 ; Vol. 13, No. 3. pp. 240-249.
@article{25923d834a6e474495fd5c9b947212df,
title = "Radiation Therapy for Colorectal Liver Metastases",
abstract = "Purpose of Review: The purpose of the present study is to review the management of colorectal liver metastases (CLM) with radiation therapy (RT). Recent Findings: Conventional RT is a local-regional modality that may provide symptomatic palliation, local control, and potential for prolongation of survival. Studies of RT to the liver contributed to understanding of the volume effect of liver toxicity and the potential for dose escalation to limited volumes. Stereotactic body radiation therapy (SBRT) delivers highly conformal ablative doses, providing high rates of local control without associated increases in toxicity. Radioembolization can provide local control for chemorefractory patients, but its added value in the first-line setting with modern systemic therapy remains an area of active investigation. Summary: SBRT and radioembolization play key roles in the modern management of patients with CLM who are not eligible for surgery. Patients with limited burden of intrahepatic disease may be ideally suited for SBRT, while those with higher number (≥3) of CLM may be more appropriate for transarterial radioembolization.",
keywords = "Colorectal liver metastases, External beam radiation therapy, Radioembolization, Stereotactic body radiation therapy",
author = "Yushen Qian and Kumar, {Kiran A.} and Sara Dudley and Koong, {Albert C.} and Chang, {Daniel T.}",
year = "2017",
month = "6",
day = "1",
doi = "10.1007/s11888-017-0368-3",
language = "English (US)",
volume = "13",
pages = "240--249",
journal = "Current Colorectal Cancer Reports",
issn = "1556-3790",
publisher = "Springer Science + Business Media",
number = "3",

}

TY - JOUR

T1 - Radiation Therapy for Colorectal Liver Metastases

AU - Qian, Yushen

AU - Kumar, Kiran A.

AU - Dudley, Sara

AU - Koong, Albert C.

AU - Chang, Daniel T.

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Purpose of Review: The purpose of the present study is to review the management of colorectal liver metastases (CLM) with radiation therapy (RT). Recent Findings: Conventional RT is a local-regional modality that may provide symptomatic palliation, local control, and potential for prolongation of survival. Studies of RT to the liver contributed to understanding of the volume effect of liver toxicity and the potential for dose escalation to limited volumes. Stereotactic body radiation therapy (SBRT) delivers highly conformal ablative doses, providing high rates of local control without associated increases in toxicity. Radioembolization can provide local control for chemorefractory patients, but its added value in the first-line setting with modern systemic therapy remains an area of active investigation. Summary: SBRT and radioembolization play key roles in the modern management of patients with CLM who are not eligible for surgery. Patients with limited burden of intrahepatic disease may be ideally suited for SBRT, while those with higher number (≥3) of CLM may be more appropriate for transarterial radioembolization.

AB - Purpose of Review: The purpose of the present study is to review the management of colorectal liver metastases (CLM) with radiation therapy (RT). Recent Findings: Conventional RT is a local-regional modality that may provide symptomatic palliation, local control, and potential for prolongation of survival. Studies of RT to the liver contributed to understanding of the volume effect of liver toxicity and the potential for dose escalation to limited volumes. Stereotactic body radiation therapy (SBRT) delivers highly conformal ablative doses, providing high rates of local control without associated increases in toxicity. Radioembolization can provide local control for chemorefractory patients, but its added value in the first-line setting with modern systemic therapy remains an area of active investigation. Summary: SBRT and radioembolization play key roles in the modern management of patients with CLM who are not eligible for surgery. Patients with limited burden of intrahepatic disease may be ideally suited for SBRT, while those with higher number (≥3) of CLM may be more appropriate for transarterial radioembolization.

KW - Colorectal liver metastases

KW - External beam radiation therapy

KW - Radioembolization

KW - Stereotactic body radiation therapy

UR - http://www.scopus.com/inward/record.url?scp=85017499285&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017499285&partnerID=8YFLogxK

U2 - 10.1007/s11888-017-0368-3

DO - 10.1007/s11888-017-0368-3

M3 - Review article

AN - SCOPUS:85017499285

VL - 13

SP - 240

EP - 249

JO - Current Colorectal Cancer Reports

JF - Current Colorectal Cancer Reports

SN - 1556-3790

IS - 3

ER -